Central Drug Agency Seeks Clarification From Glenmark On Its COVID Drug

The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...

from NDTV News - Special https://ift.tt/3jjsiDu

Comments

Popular posts from this blog

Viral Video Shows 3,000 Engineers Queuing Up For Job Interview In Pune

Asteroid Discovery Suggests Ingredients for Life on Earth Came From Space

Smith's Horrible DRS Call Has Kohli In Splits. 'Worst Review' Says Twitter